{"id":"W2762414606","doi":"10.1093/annonc/mdx440.051","title":"ABOUND.2L+: nab-paclitaxel (nab-P) +/- CC-486 or durvalumab in previously treated patients with advanced non-small cell lung cancer (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Durvalumab; Neutropenia; Internal medicine; Gastroenterology; Adverse effect; Lung cancer; Chemotherapy; Surgery; Urology; Cancer; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000474891,0.0004059798,0.0009217238,0.000221843,0.0002101713,0.0004455557,0.0004184611,0.000461958,0.001951127],"category_scores_gemma":[0.0004442937,0.0001850774,0.000612775,0.0002801247,0.0002583412,0.0005054002,0.0001834169,0.0009569511,0.0003906703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000630075,"about_ca_system_score_gemma":0.000694989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0017162,"about_ca_topic_score_gemma":0.007217546,"domain_scores_codex":[0.9998307,0.00005224062,0.00001424296,0.00003180139,0.00001860948,0.00005241953],"domain_scores_gemma":[0.9998391,0.0000298684,0.00002409538,0.000009908274,0.000006667375,0.00009032361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.449055,0.007732875,0.0831368,0.0009207026,0.002209394,0.001993287,0.0002543603,0.00259736,0.04291847,0.0006280314,0.01158178,0.396972],"study_design_scores_gemma":[0.2087054,0.2800561,0.4262718,0.00031748,0.005476481,0.006705002,0.000400497,0.007272307,0.02340934,0.0008789223,0.04034664,0.0001599917],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.9887953,0.006732771,0.0001268193,0.000638436,0.000228853,0.00009984995,0.0004301763,0.00006564213,0.002882129],"genre_scores_gemma":[0.9953911,0.002141133,0.0002593152,0.0002858436,0.0001165071,0.00006201435,0.0005494971,0.00001072211,0.00118392],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.001951127,"threshold_uncertainty_score":0.006527185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03829033952117692,"score_gpt":0.3702188285745939,"score_spread":0.3319284890534169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}